S2CID 452394
The paradigm shift that began with EMPA-REG OUTCOME and LEADER has led to SGLT2 inhibitors and GLP-1 RA being recognised not only in international diabetes guidelines, but also as an important consideration for patients with T2D in CVD prevention [28,29,30, 76, 77], HF [133,134,135] and CKD [41, 102] guidelines, where it has been suggested that these agents should be considered early in the course of diabetes management
Nonetheless, Semaglutide is accessible in both tablet and injection forms, implying that it can be delivered in different ways to most of its patients
It previously said in court documents that gastrointestinal symptoms are known and labeled side effects
The dosage may be increased to 9 mg, 14.5 mg, or 17.2 mg after at least 30 days at each level based on treatment response and tolerability, according to the FDA
This innovative medication has gained attention for its role in effective and successful weight loss